Great Highlights. Rev for 3Q a little under my expectations but certainly acceptable:
Q3 ACTIVITIES REPORT 31 MARCH 2025
Highlights
$7.2 million Q3 Revenue - 352% increase on Q3 FY2024
$8.5 million Q3 Cash Receipts - 14% increase on prior quarter and 238%increase on Q3 FY2024
Year to date Revenue of $19.7 million - up 213% on YTD Q3 FY2024.
On track to exceed FY2025 revenue forecast of $25 million
Positive Q3 cash flow of $1.9 million with increased investment in workingcapital to fund growing sales
Capital raise in Q3 of $3.0 million (before costs)
Cash on hand $6.5 million
Increased manufacturing capacity from investment in plant and equipment of$0.9 million during Q3
New $7 million manufacturing and supply contract executed for FY2026
- Forums
- ASX - By Stock
- BXN
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
BXN
bioxyne limited
Add to My Watchlist
12.9%
!
2.7¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
-0.004(12.9%) |
Mkt cap ! $58.45M |
Open | High | Low | Value | Volume |
3.1¢ | 3.2¢ | 2.7¢ | $249.2K | 8.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1096318 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 937059 | 0.027 |
7 | 1944230 | 0.026 |
12 | 1770185 | 0.025 |
8 | 3261929 | 0.024 |
3 | 354500 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 150000 | 1 |
0.030 | 251214 | 1 |
0.031 | 689483 | 1 |
0.032 | 312042 | 1 |
0.033 | 600000 | 1 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
BXN (ASX) Chart |